1. Home
  2. SB vs IRWD Comparison

SB vs IRWD Comparison

Compare SB & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe Bulkers Inc ($0.001 par value)

SB

Safe Bulkers Inc ($0.001 par value)

HOLD

Current Price

$6.82

Market Cap

651.7M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.88

Market Cap

658.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SB
IRWD
Founded
2007
1998
Country
Monaco
United States
Employees
1107
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
651.7M
658.5M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
SB
IRWD
Price
$6.82
$3.88
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$6.00
$7.67
AVG Volume (30 Days)
1.0M
2.7M
Earning Date
05-18-2026
05-11-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.24
Revenue
N/A
$298,276,000.00
Revenue This Year
$3.47
$57.95
Revenue Next Year
$3.61
$4.39
P/E Ratio
$16.77
$16.10
Revenue Growth
N/A
8.88
52 Week Low
$3.61
$0.72
52 Week High
$7.38
$5.78

Technical Indicators

Market Signals
Indicator
SB
IRWD
Relative Strength Index (RSI) 51.55 45.35
Support Level $6.29 $3.80
Resistance Level $7.30 $3.95
Average True Range (ATR) 0.22 0.24
MACD 0.04 -0.07
Stochastic Oscillator 57.02 7.51

Price Performance

Historical Comparison
SB
IRWD

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: